MedTrace Logo

Cognitive Impact of Paracetamol in Healthy Volunteers

NCT01390467 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2012-01-30

No results posted yet for this study

Summary

Randomized study, double-blind, crossover, controlled versus placebo.

Conditions

  • Healthy

Interventions

DRUG

Cantab®

Randomized study, double-blind, crossover, controlled versus placebo.

Sponsors & Collaborators

  • Grünenthal GmbH

    collaborator INDUSTRY

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Gisèle PICKERING · University Hospital, Clermont-Ferrand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-07-31
Completion
2012-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01390467 on ClinicalTrials.gov